Request Deal Involvement
Sanofi completed the acquisition of Inhibrx for $1.7bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors to financial advisors
Skadden Arps Slate Meagher & Flom
legal advisors
Paul Weiss Rifkind Wharton & Garrison
financial advisors
Centerview Partners
financial advisors
Eight Advisory
pr advisors
Brunswick Group
financial advisors
Lazard
legal advisors
Weil Gotshal and Manges
or
Principals
target
INHIBRX
bidder
SANOFI SA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite